Interacting Drugs |
Pegylated interferon (peginterferon) alfa-2a and ribavirin vs Aldesleukin |
Mechanism |
Aldesleukin: Interferons (Alfa) may enhance the adverse/toxic effect of Aldesleukin. In particular, risks of myocardial and renal toxicity may be increased by this combination. |
Management |
Consider therapy modification |
Pegylated interferon (peginterferon) alfa-2a and ribavirin vs Aldesleukin
Post Review about Pegylated interferon (peginterferon) alfa-2a and ribavirin vs Aldesleukin Click here to cancel reply.
Other Interactions of Pegylated interferon (peginterferon) alfa-2a and ribavirin
Other Interactions of Aldesleukin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.